Phase I Study of a Herpes Simplex Virus Type 2 (HSV-2) DNA Vaccine Administered to Healthy, HSV-2-Seronegative Adults by a Needle-Free Injection System

• Published in: Clinical and Vaccine Immunology Vol. 15; no. 11; pp. 1638 - 1643
• Main Authors: Cattamanchi, Ashok, Posavad, Christine M, Wald, Anna, Baine, Yaela, Moses, Jennifer, Higgins, Terry J, Ginsberg, Richard, Ciccarelli, Richard, Corey, Lawrence, Koelle, David M
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 01.11.2008; American Society for Microbiology (ASM)
• Subjects: Adult; Cell Proliferation; Cytotoxicity Tests, Immunologic; Double-Blind Method; Female; Herpes Simplex Virus Vaccines - administration & dosage; Herpes Simplex Virus Vaccines - adverse effects; Herpes Simplex Virus Vaccines - genetics; Herpes Simplex Virus Vaccines - immunology; Herpesvirus 2, Human - genetics; Herpesvirus 2, Human - immunology; Humans; Immunization, Secondary; Injections - methods; Male; Middle Aged; Placebos - administration & dosage; Plasmids; T-Lymphocytes, Cytotoxic - immunology; Vaccination - methods; Vaccine Research; Vaccines, DNA - administration & dosage; Vaccines, DNA - adverse effects; Vaccines, DNA - genetics; Vaccines, DNA - immunology; Viral Envelope Proteins - genetics; Viral Envelope Proteins - immunology
• ISSN: 1556-6811; 1556-679X
• DOI: 10.1128/CVI.00167-08

Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy CVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 1556-6811 Online ISSN: 1556-679X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to CVI .asm.org, visit: CVI